secwatch.observer — SEC 8-K summary
======================================

Issuer:     Clearside Biomedical, Inc. (CLSDQ)
CIK:        0001539029
Form:       8-K
Filed at:   2023-12-28T23:59:59+00:00
Accession:  0000950170-23-073587
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Clearside Biomedical waives $12.5M milestone payment, releases escrow to HCR
----------------------------------------------------------------------------

- Subsidiary Clearside Royalty waived all rights to $12.5M milestone payment tied to XIPERE sales.
- Payment held in escrow under 2022 Purchase Agreement; released to Healthcare Royalty Partners IV.
- First Milestone Event required milestone by March 31, 2024; waiver eliminates potential payment.
- Escrow agreement terminated upon release of funds to purchaser.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1539029/000095017023073587/0000950170-23-073587-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1539029/000095017023073587/clsd-20231222.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-073587

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer